About The Society for Brain Mapping and Therapeutics (SBMT)
501(c)(6) Non-Profit Organization
SBMT is organized to encourage scientists focused on Brain Mapping, engineering, stem cell, nanotechnology, imaging and medical devices to improve the diagnosis, treatment and rehabilitation of patients afflicted with neurological disorders.
Society For Brain Mapping And Therapeutics
SBMT is a non-profit society organized for the purpose of encouraging basic and clinical scientists as well as engineers who are interested in areas of Brain Mapping and Therapeutics to improve the diagnosis, treatment, and rehabilitation of patients afflicted with neurological disorders.
This society promotes public welfare and improves patient care by translating new technologies into lifesaving diagnostic and therapeutic procedures. The society is committed to excellence in education and scientific discovery. The society achieves its mission through multi-disciplinary collaborations with government agencies, patient advocacy groups, educational institutes, the private sector (industry), and philanthropic organizations.
The Society for Brain Mapping and Therapeutics (SBMT) was founded in 2004 to break boundaries in healthcare. The Society promotes policies that support rapid, safe, and cost-effective translation of new technology into medicine. The SBMT globally promotes interdisciplinary research to improve the diagnosis, treatment, and rehabilitation of patients with central nervous system diseases regardless of race, creed, color, national origin, gender, or age. The SBMT catalyzes interactions between clinical, biological, physical, and engineering sciences. The Society builds transdisciplinary and translational consortia, which break down traditional barriers that impede the application of new technology to medical problems.
“The Society for Brain Mapping and Therapeutics was founded in 2004 to break the boundaries of science, Technology, Medicine, Art & Healthcare Policy.”
Translational research applies cutting-edge basic science and advanced technologies to clinical neurosciences. The Society examines emerging disciplines such as nanotechnology, image-guided therapy, stem cell therapy, multi-modality imaging, biophotonics, and biomaterial and tissue engineering for their application to diagnose, treat, and rehabilitate neurological diseases. The Society seeks to apply these technologies to clinical problems such as brain tumors, stroke, epilepsy, neurodegenerative diseases (Parkinson, Alzheimer, multiple sclerosis, and ALS), traumatic brain and spinal cord injuries, autism, post-traumatic stress disorder, and other psychiatric illnesses. The Society achieves its goals through meetings, fellowships, publications, international collaborations, consortiums, and policy forums. The SBMT is a nonprofit society that has obtained support from many government agencies (USA, EU, and Asia), foundations, and multinational corporations.
We are committed to creating a workplace where all employees feel welcome, respected, and included, regardless of their sexual orientation or gender identity. We believe that diversity and inclusion are essential to our success, and we are committed to creating an environment where everyone can thrive.
The Society maintains its headquarters in Pacific Palisades, CA
Babak Kateb started the organization out of the collaboration between NASA/JPL-USC-Keck School of Medicine and Caltech through an initial meeting at NASA/JPL attended by 15 scientists from those institutions back in 2003. The meeting was co-organized by Wolfgang Fink (NASA/JPL), John George (NASA/JPL), and Babak Kateb (USC-Keck School). Thus, the official color of the organization is Maroon and Gold. This initial think-tank meeting gradually grew into a larger international think-tank convention.
In 2004, Babak Kateb, Farzad Massoudi, and Warren Grundfest filled out the necessary legal and tax paperwork with the US IRS and obtained approval from IRS for a 501c6 Non-Profit multidisciplinary and multi-specialty biomedical association. Later it has grown to encompass engineers, scientists, physicians, surgeons, policymakers, healthcare executives, and investors.
The initial name of the organization was: International Brain Mapping & Intra-operative Surgical Planning Society (IBMISPS).
The name was aimed at the international nature of the organization, its clinical and basic science approach toward brain mapping, and image-guided surgery/therapeutics.
In 2011 Mike Chen, the 9th SBMT president, then President-elect of IBMISPS, proposed a name change for the organization to capture its mission and impact better. Many names were presented, including “International Society for Brain Mapping and Therapeutics (ISBMT)” and “Society for Brain Mapping and Therapeutics (SBMT).” The members voted to choose Society for Brain Mapping and Therapeutics (SBMT) as the new name for the organization in its 8th Annual World Brain Mapping meeting at UCSF in 2011.
Since its foundation in 2004, SBMT has relentlessly promoted policies that support the rapid, safe, and cost-effective translation of new and emerging technology into diagnostic and therapeutics.
SBMT played a significant role in formulating, planning, and executing President Barak Obama’s BRAIN Initiative.
In 2013, SBMT pioneered the G20+ World Brain Mapping & Therapeutic Initiative, renamed Neuroscience20 (Brain, Spine, and Mental Health). This initiative aims to create a global consortium integrating nanotechnology, imaging, cellular/stem cell therapeutics, information technology, and devices in Brain Mapping.
Become a Member
Join our community of 100,000+ Neuroscientists who are diverse in expertise and united in purpose.
What we do
Topics for research papers:
- Healthcare Policy, Ethics, and Regulatory Affairs
- Functional Brain Mapping (fMRI, PET, SPECT…)
- Molecular and Cellular Imaging, Nano-Particles, Stem Cell, and T-cell Imaging
- Image-guided Systems for Surgery, Vascular & Blood Flow Imaging
- Brain Mapping in Stereotactic Radiosurgery
- Neurophysiology (EEG, MEG…)
- Biophotonics, Nanoscience, Genomics
- Neural Prosthesis & Robotics, Brain Computer Interface Technology
- Multimodality Imaging and Ultrasound
- Magnetic Resonance Spectroscopic Imaging, High-field, and Low-field
- Transcranial Magnetic Stimulation
- Diffusion Tensor Imaging
- Mental Health Disorders (PTSD, addictions…)
- Neurodegenerative Disorders (Alzheimer’s, Parkinson’s, ALS, MS…)
- Military Medicine and Neurotrauma (TBI, micro-TBI)
- Epilepsy and Neuromodulation
- Rehabilitation Medicine
- Economic Burden of Neurological Diseases
- Grants and Asset Management (Investment and Start-up spinoff…)
Conferences and Events
- Annual World Congress of SBMT (Q1 annually)
- Neuroscience20 – N20 (Brain, Spine and Mental Health) Annual Summit (G20 summit)
- A+ (African) Brain Initiative (Q1 annually)
- LA+ (Latin America) Brain Initiative (Q2 annually)
- ME+ (Middle East) Brain Initiative (Q2-3 annually)
- AP+ (Asia-Pacific) Brain Initiative (Q3 annually)
Multidisciplinary – Multispecialty online working groups
Fellowships and Interships (Volunteers)
Fellowships (Research, Policy, and Global Health)
- Doctoral and Postdoctoral
- Master’s Degree
- Graduate Non-Medical
(IBMISPS-Tax ID 20-2793206)